Sale

Electrophysiology Devices Market

Global Electrophysiology Devices Market Size, Share, Growth: By Type: Treatment Devices, Diagnostic Devices; By Indication: Atrial Fibrillation (AF), Supraventricular Tachycardia (SVT), Atrioventricular Nodal Re-Entry Tachycardia (AVNRT), Others; By End User: Hospitals, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Electrophysiology Devices Market Outlook

The global Electrophysiology Devices market value was USD 6.82 billion in 2023, driven by the increasing prevalence of cardiac arrhythmias across the globe. The market size is anticipated to grow at a CAGR of 10% during the forecast period of 2024-2032 to achieve a value of USD 16.08 billion by 2032.

 

Global Electrophysiology Devices Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The growth of the global electrophysiology devices market is fuelled by factors such as the emergence of technologically advanced electrophysiology products, the rapid growth in the ageing population with a high risk of target diseases, increased incidences of cases of arrhythmia across the globe, and the growing focus of key market players to broaden their geographic presence.

 

Market Segmentation

Electrophysiology is the branch of physiology, which is loosely related to the flow of ions (ion current) in biological tissues and, in general, to the electrical recording techniques which enable this flow to be measured.

 

Global Electrophysiology Devices Market By End Use

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The electrophysiology devices market can be segmented into type, indication, and end-use.

The industry can be broadly categorised on the basis of its type into:

  • EP Ablation Catheters
  • Cryoablation EP Catheters
  • Radiofrequency Ablation Catheters
  • Laser Ablation Systems
  • Microwave Ablation Systems
  • EP Diagnostic Catheters
  • Conventional EP Diagnostic Catheters
  • Advanced EP Diagnostic Catheters
  • Ultrasound EP Diagnostic Catheters
  • EP Laboratory Devices
  • Access Devices
  • Others

The industry can be divided based on indication as:

  • Atrial Fibrillation (AF)
  • Atrioventricular Nodal Re-entry Tachycardia (AVNRT) 
  • Wolff-Parkinson-White Syndrome (WPW) 
  • Atrial Flutter
  • Others

Based on its end-use segments, the industry can be categorised as:

  • Hospitals
  • Diagnostic Centres
  • Clinics
  • Others

The EMR report looks into the regional electrophysiology devices markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.

 

Global Electrophysiology Devices Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The increasing use of electrophysiological devices in the diagnosis and treatment of heart diseases such as atrial fibrillation, increased demand for cardiac rhythm management devices for continuous monitoring, and the increased use of these devices in out-of-hospital settings are some of the high-impact drivers for the electrophysiology devices market growth. The rising prevalence of heart failure and cardiac attack cases among millennials due to lifestyle habits such as smoking, and the high consumption of alcohol are the major driving factors for the electrophysiology devices market growth.

The lack of skilled and trained electrophysiologists in the developing countries and unfavourable healthcare reforms in the United States are hampering the development of the electrophysiology devices market. The main challenges faced by market players are the rising price pressure on players in the market and stringent regulations.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global electrophysiology devices market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Abbott Laboratories 
  • Siemens Healthcare AG
  • Nihon Kohden Corporation
  • Boston Scientific Corporation
  • General Electric Company
  • Medtronic plc
  • Koninklijke Philips N.V.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Indication
  • End User
  • Region
Breakup by Type
  • Treatment Devices
  • Diagnostic Devices
Breakup by Indication
  • Atrial Fibrillation (AF)
  • Supraventricular Tachycardia (SVT)
  • Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)
  • Wolff-Parkinson-White Syndrome (WPW)
  • Bradycardia
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Johnson & Johnson Private Limited
  • BIOTRONIK SE & Co KG
  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • BD
  • Baxter
  • Koninklijke Philips N.V.
  • General Electric
  • Medline Industries, Inc.
  • Danaher
  • Siemens Healthcare GmbH
  • MicroPort Scientific Corporation
  • LivaNova PLC
  • Cardiofocus
  • Mogul Enterprises, Inc.
  • AtriCure, Inc.
  • Japan Lifeline Co., Ltd.
  • ARGON MEDICAL
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Electrophysiology Devices Market Overview 

    3.1    Global Electrophysiology Devices Market Historical Value (2017-2023) 
    3.2    Global Electrophysiology Devices Market Forecast Value (2024-2032)
4    Global Electrophysiology Devices Market Landscape
    4.1    Global Electrophysiology Devices Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Electrophysiology Devices Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Indication
        4.2.3    Analysis by End User
5    Global Electrophysiology Devices Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Electrophysiology Devices Market Segmentation
    6.1    Global Electrophysiology Devices Market by Type
        6.1.1    Market Overview    
        6.1.2    Treatment Devices
            6.1.2.1    Implantable Cardioverter Defibrillators (ICDs)
            6.1.2.2    Automated external defibrillators (AEDs)
            6.1.2.3    Pacemakers
                6.1.2.3.1    CRT-P
                6.1.2.3.2    CRT-D
                6.1.2.3.3    Catheters
                6.1.2.3.4    Others
        6.1.3    Diagnostic Devices
            6.1.3.1    Holter Monitoring Devices
            6.1.3.2    Diagnostic Electrophysiology Catheters
            6.1.3.3    Electrocardiograph (ECG)
            6.1.3.4    EP Mapping & Imaging Systems
            6.1.3.5    Insertable cardiac monitors (ICM)
            6.1.3.6    Others
    6.2    Global Electrophysiology Devices Market by Indication
        6.2.1    Market Overview
        6.2.2    Atrial Fibrillation (AF)
        6.2.3    Supraventricular Tachycardia (SVT)
        6.2.4    Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)
        6.2.5    Wolff-Parkinson-White Syndrome (WPW)
        6.2.6    Bradycardia
        6.2.7    Others
    6.3    Global Electrophysiology Devices Market by End User
        6.3.1    Market Overview
        6.3.2    Hospitals
        6.3.3    Specialty Clinics
        6.3.4    Ambulatory Surgical Centers
        6.3.5    Others
    6.4    Global Electrophysiology Devices Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Electrophysiology Devices Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Electrophysiology Devices Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Electrophysiology Devices Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Electrophysiology Devices Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Electrophysiology Devices Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Johnson & Johnson Private Limited
        17.1.1    Financial Analysis
        17.1.2     Product Portfolio
        17.1.3     Demographic Reach and Achievements
        17.1.4     Mergers and Acquisitions
        17.1.5     Certifications
    17.2    BIOTRONIK SE & Co KG
        17.2.1    Financial Analysis
        17.2.2     Product Portfolio
        17.2.3     Demographic Reach and Achievements
        17.2.4     Mergers and Acquisitions
        17.2.5     Certifications
    17.3    Abbott
        17.3.1    Financial Analysis
        17.3.2     Product Portfolio
        17.3.3     Demographic Reach and Achievements
        17.3.4     Mergers and Acquisitions
        17.3.5     Certifications
    17.4    Medtronic
        17.4.1    Financial Analysis
        17.4.2     Product Portfolio
        17.4.3     Demographic Reach and Achievements
        17.4.4     Mergers and Acquisitions
        17.4.5     Certifications
    17.5    Boston Scientific Corporation
        17.5.1    Financial Analysis
        17.5.2     Product Portfolio
        17.5.3     Demographic Reach and Achievements
        17.5.4     Mergers and Acquisitions
        17.5.5     Certifications
    17.6     B. Braun Melsungen AG
        17.6.1    Financial Analysis
        17.6.2     Product Portfolio
        17.6.3     Demographic Reach and Achievements
        17.6.4     Mergers and Acquisitions
        17.6.5     Certifications
    17.7     BD
        17.7.1    Financial Analysis
        17.7.2     Product Portfolio
        17.7.3     Demographic Reach and Achievements
        17.7.4     Mergers and Acquisitions
        17.7.5     Certifications
    17.8     Baxter
        17.8.1    Financial Analysis
        17.8.2     Product Portfolio
        17.8.3     Demographic Reach and Achievements
        17.8.4     Mergers and Acquisitions
        17.8.5     Certifications
    17.9     Koninklijke Philips N.V.
        17.9.1    Financial Analysis
        17.9.2     Product Portfolio
        17.9.3     Demographic Reach and Achievements
        17.9.4     Mergers and Acquisitions
        17.9.5     Certifications
    17.10    General Electric
        17.10.1    Financial Analysis
        17.10.2     Product Portfolio
        17.10.3     Demographic Reach and Achievements
        17.10.4     Mergers and Acquisitions
        17.10.5     Certifications
    17.11     Medline Industries, Inc.
        17.11.1    Financial Analysis
        17.11.2     Product Portfolio
        17.11.3     Demographic Reach and Achievements
        17.11.4     Mergers and Acquisitions
        17.11.5     Certifications
    17.12     Danaher
        17.12.1    Financial Analysis
        17.12.2     Product Portfolio
        17.12.3     Demographic Reach and Achievements
        17.12.4     Mergers and Acquisitions
        17.12.5     Certifications
    17.13     Siemens Healthcare GmbH
        17.13.1    Financial Analysis
        17.13.2     Product Portfolio
        17.13.3     Demographic Reach and Achievements
        17.13.4     Mergers and Acquisitions
        17.13.5     Certifications
    17.14     MicroPort Scientific Corporation
        17.14.1    Financial Analysis
        17.14.2     Product Portfolio
        17.14.3     Demographic Reach and Achievements
        17.14.4     Mergers and Acquisitions
        17.14.5     Certifications
    17.15    LivaNova PLC 
        17.15.1    Financial Analysis
        17.15.2     Product Portfolio
        17.15.3     Demographic Reach and Achievements
        17.15.4     Mergers and Acquisitions
        17.15.5     Certifications
    17.16    Cardiofocus
        17.16.1    Financial Analysis
        17.16.2     Product Portfolio
        17.16.3     Demographic Reach and Achievements
        17.16.4     Mergers and Acquisitions
        17.16.5     Certifications
    17.17    Mogul Enterprises, Inc.
        17.17.1    Financial Analysis
        17.17.2     Product Portfolio
        17.17.3     Demographic Reach and Achievements
        17.17.4     Mergers and Acquisitions
        17.17.5     Certifications
    17.18     AtriCure, Inc. 
        17.18.1    Financial Analysis
        17.18.2     Product Portfolio
        17.18.3     Demographic Reach and Achievements
        17.18.4     Mergers and Acquisitions
        17.18.5     Certifications
    17.19    Japan Lifeline Co., Ltd.
        17.19.1    Financial Analysis
        17.19.2     Product Portfolio
        17.19.3     Demographic Reach and Achievements
        17.19.4     Mergers and Acquisitions
        17.19.5     Certifications
    17.20     ARGON MEDICAL
        17.20.1    Financial Analysis
        17.20.2     Product Portfolio
        17.20.3     Demographic Reach and Achievements
        17.20.4     Mergers and Acquisitions
        17.20.5     Certifications
18    Global Electrophysiology Devices Market-Distribution Model (Additional Insight)
    18.1    Overview
    18.2    Potential Distributors
    18.3    Key Parameters for Distribution Partner Assessment
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Pricing Models and Strategies (Additional Insight)
    21.1    Overview
    21.2    Cost Model
        21.2.1    Manufacturing Cost Analysis
        21.2.2    Procurement Cost Analysis
        21.2.3    Clinical Trial Cost Factors
    21.3    Pricing Strategies
        21.3.1     Competitor Pricing Analysis
        21.3.2     Key Assessment of Product Attributes
        21.3.3     Pricing Benchmark

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The Electrophysiology Devices Market was valued at USD 6.82 billion in 2023.

The market is expected to grow at a CAGR of 10% from 2024 to 2032 to reach a value of USD 16.08 billion by 2032.

The major drivers of the market are the increased incidences of cases of arrhythmia worldwide, growth in the ageing population, and the rising focus of key market players.

The key trends guiding the market growth include the rising prevalence of heart failure and cardiac attack cases among millennials and emergence of technologically advanced electrophysiology products.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading types of electrophysiology devices in the market are EP ablation catheters, EP diagnostic catheters, EP laboratory devices, and access devices, among others.

The major indications in the market are atrial fibrillation (AF), atrioventricular nodal re-entry tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), and atrial flutter, among others.

The leading end uses in the electrophysiology devices market are hospitals, diagnostic centres, and clinics, among others.

The major players in the market are Abbott Laboratories, Siemens Healthcare AG, Nihon Kohden Corporation, Boston Scientific Corporation, General Electric Company, Medtronic plc, and Koninklijke Philips N.V., among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER